| 3.75 0.75 (25%) | 10-01 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.05 |
1-year : | 5.9 |
| Resists | First : | 4.32 |
Second : | 5.05 |
| Pivot price | 3.15 |
|||
| Supports | First : | 3.41 |
Second : | 2.85 |
| MAs | MA(5) : | 3.15 |
MA(20) : | 3.22 |
| MA(100) : | 4.19 |
MA(250) : | 5.22  |
|
| MACD | MACD : | -0.2 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 45.5 |
D(3) : | 26.7 |
| RSI | RSI(14): 58.7 |
|||
| 52-week | High : | 16.15 | Low : | 2.85 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ OM ] has closed Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.89 - 3.92 | 3.92 - 3.94 |
| Low: | 2.82 - 2.84 | 2.84 - 2.86 |
| Close: | 3.71 - 3.76 | 3.76 - 3.79 |
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Wed, 12 Aug 2026
AQR Capital discloses 5.39% Outset Medical (OM) ownership in Schedule 13G - Stock Titan
Fri, 07 Aug 2026
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic HCA ... - finance.yahoo.com
Thu, 06 Aug 2026
Outset Medical Reports Second Quarter 2026 Results - GlobeNewswire
Thu, 06 Aug 2026
Outset Medical (OM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Sat, 25 Jul 2026
Outset Medical, Inc. Revenue Breakdown – NASDAQ:OM - TradingView
Fri, 24 Jul 2026
Outset Medical Inc. (OM) Extends Decline as Shares Slip Below $4.10 Mark - Option Breadth - careplusvn.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 19 (M) |
| Shares Float | 15 (M) |
| Held by Insiders | 4.9 (%) |
| Held by Institutions | 73.9 (%) |
| Shares Short | 936 (K) |
| Shares Short P.Month | 1,220 (K) |
| EPS | -3.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.11 |
| Profit Margin | -63.1 % |
| Operating Margin | -49.6 % |
| Return on Assets (ttm) | -15.6 % |
| Return on Equity (ttm) | -59.2 % |
| Qtrly Rev. Growth | 0.6 % |
| Gross Profit (p.s.) | 2.61 |
| Sales Per Share | 6.26 |
| EBITDA (p.s.) | -3.34 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -38 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | -0.99 |
| PEG Ratio | 0 |
| Price to Book value | 0.73 |
| Price to Sales | 0.59 |
| Price to Cash Flow | -1.84 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|